Chiesi Pharmaceuticals

Chiesi Farmaceutici S.p.A. is an international, privately managed pharmaceutical company headquartered in Parma, Italy. Founded in 1935, Chiesi specializes in the research, development, and commercialization of innovative therapeutic solutions in respiratory health, neonatology, rare diseases, and special care. The company operates in over 100 countries, employing more than 7,500 people across 31 subsidiaries worldwide. Chiesi's products are marketed globally, with manufacturing facilities in Parma, Italy; Blois, France; and Santana de Parnaíba, Brazil. The company's research and development centers are located in Parma (Italy), Paris (France), Cary (USA), Chippenham (UK), and the R&D team from the newly acquired Danish company Zymenex.